SavedAdd your journal

Journals / Turkish Journal of Hematology / 2020 / Cilt: 37 - Sayı: 4

Chronic Lymphocytic Leukemia with Dermatomyositis: A Therapeutic Challenge

Dermatomyozitle Birlikte Kronik Lenfositik Lösemi: Bir Tedavi Mücadelesi

Ritu GUPTA
Sudhir KUMAR
Ajay GOGIA
Soumya MALLICK
Soumya MALLICK
Pages
291–292
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

GUPTA, R., KUMAR, S., GOGIA, A., MALLICK, S., MALLICK, S. (2022). Chronic Lymphocytic Leukemia with Dermatomyositis: A Therapeutic Challenge. Turkish Journal of Hematology, Cilt: 37 - Sayı: 4, 291–292. https://ajindex.com/articles/606613

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (6)

  1. Hamblin TJ. Non-hemic autoimmunity in CLL. Leuk Res 2009;33:366-367
  2. Stübgen JP. Inflammatory myopathies and lymphoma. J Neurol Sci 2016;369:377-389
  3. Kay NE. Abnormal T-cell subpopulation function in CLL: excessive suppressor (T gamma) and deficient helper (T mu) activity with respect to B-cell proliferation. Blood 1981;57:418-420
  4. Gunawardena H, Betteridge ZE, McHugh NJ. Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression. Rheumatology (Oxford) 2009;48:607-612
  5. Marie I, Guillevin L, Menard JF, Hatron PY, Cherin P, Amoura Z, Cacoub P, Bachelez H, Buzyn A, Le Roux G, Ziza JM, Brice P, Munck JN, SarrotReynauld F, Piette JC, Larroche C. Hematological malignancy associated with polymyositis and dermatomyositis. Autoimmun Rev 2012;11:615-620
  6. Levine TD. Rituximab in the treatment of dermatomyositis: an open-label pilot study. Arthritis Rheum 2005;52:601-607.